Screener
Pacific Biosciences of California PACB Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Consumable revenue | $20.11M+6.2% | $21.81M+8.5% | $21.63M+15.0% | $21.28M+15.0% | $18.93M+10.9% | |
| Instrument revenue | $12.84M-9.3% | $9.72M-11.8% | $17.34M+13.4% | $11.32M-32.6% | $14.15M-3.6% | |
| Service and other revenue | $6.06M-9.4% | $5.64M-6.6% | —— | $5.84M+25.1% | $6.68M+56.6% | |
| Total Revenue by Geography | ||||||
| Americas | $17.62M-0.4% | $16.69M+2.3% | $20.71M+2.7% | $18.1M-10.0% | $17.69M-14.8% | |
| Asia-Pacific | $6.96M-44.8% | $9.72M-16.2% | $9.34M+4.3% | $9.59M-10.7% | $12.61M+53.2% | |
| Europe, Middle East and Africa | $14.43M+52.4% | $10.77M+16.5% | $14.59M+44.5% | $10.75M+17.9% | $9.47M+34.8% |
FAQ
- How does Pacific Biosciences of California break its business down?
- Pacific Biosciences of California (PACB) reports total revenue by product across 3 parts — Consumable revenue, Instrument revenue and Service and other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Pacific Biosciences of California's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pacific Biosciences of California's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
